Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

BioAge Labs, Inc. (BIOA)

NASDAQ

$8.29

$-0.00

(-0.01%)

Pre-Market

BioAge Labs, Inc. (BIOA) Live Price Chart

Last updated: ⁦2026-09-16 10:31:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

BioAge Labs, Inc. (BIOA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.29, with a market capitalisation of $389.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.68 to $25.96. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$389.21M
Open	$8.29
Day's High	$26.62
Day's Low	$0.16
Previous Close	$8.18
Volume	1.39K
Average Volume	872.53K
P/E Ratio	--
52-Week High	$25.96
52-Week Low	$4.68
Dividend Yield	--
Earnings Date	--

BioAge Labs, Inc. (BIOA) Pre-Market Stock Price

BioAge Labs, Inc. (BIOA) is trading at $8.29 in pre-market trading as of 2026-09-16 09:01:00, up 1.34% ($0.11) from the previous close of $8.18

Pre-market trading shows how investors are pricing BIOA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

BioAge Labs, Inc. (BIOA) 7-Day Stock Price Change

Over the past seven days, BioAge Labs, Inc. (BIOA) moved from $9.59 to $8.29, representing a decline of 13.56% ($1.30).

The stock traded between $8.02 and $9.76 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 509.03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BIOA 52-Week Price Position

Position in Range: 17.0%

52W Low$4.68

52W High$25.96

BIOA is currently trading at $8.29, placing it 17.0% of the way from its 52-week low of $4.68 to its 52-week high of $25.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BioAge Labs, Inc. (BIOA)?

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

BioAge Labs, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	62
Exchange	NASDAQ
Company Website	https://www.bioagelabs.com

How to Buy BioAge Labs, Inc. (BIOA) Stock on MEXC

Eligible investors can buy real shares of BioAge Labs, Inc. (BIOA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BIOA and Place Your Order

Open the RealStocks trading page and search for BIOA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BioAge Labs, Inc. (BIOA) stock price today?

BioAge Labs, Inc. (BIOA) is currently trading at $ 8.29, up 1.34% ($0.11) from the previous close of $ 8.18. Intraday prices update in real time during regular trading hours.

2.Is BIOA stock going up or down today?

As of 2026-09-16 09:01:00, BIOA is trading at $ 8.29, up 1.34% ($0.11) from its previous close of $ 8.18. The stock has traded between $ 0.16 and $ 26.62 during today’s regular session. Past price movements do not guarantee future results.

3.What is BIOA pre-market price?

As of 2026-09-16 09:01:00, BIOA is trading at $ 8.29 in pre-market trading, up 1.34% ($0.11) from the previous close of $ 8.18. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BIOA after-hours price?

As of 2026-09-16 09:01:00, BIOA is trading at $ 8.29 in after-hours trading, up 1.36% ($0.11) from the regular-session close of $ 8.18. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BIOA stock trading now?

BIOA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BIOA sit relative to its 52-week high and low?

Over the past 52 weeks, BIOA has traded between a low of $ 4.68 and a high of $ 25.96. At $ 8.29, the stock is positioned 17.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BioAge Labs, Inc. in?

BioAge Labs, Inc. (BIOA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BioAge Labs, Inc.'s market capitalisation and where is it listed?

BioAge Labs, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 389.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BIOA valued in terms of P/E ratio and EPS?

BIOA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.06. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BioAge Labs, Inc. pay a dividend?

BioAge Labs, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.